High-billing cardiologists order more noninvasive testing when treating atrial fibrillation (AFib) than their colleagues, according to new data published in the Journal of the American Heart Association. This is not associated with better outcomes. “These results suggest the importance of aligning…
The 65-year-old male patient presented with a long medical history and many comorbidities, making surgery too risky and transcaval access was the best path forward.
How have recent FDA approvals for Edwards Lifesciences and Abbott changed patient care? Andrew Rassi, MD, answered that question—and many more—in a new interview.
The new gene therapy candidate is now one step closer to being approved by the FDA.
There have been a total of 11 incidents so far, including seven injuries and two deaths. Boston Scientific said the agent can still be used…
Biga, who originally trained as a nurse, specializes in the business side of cardiology. She also emphasized the increasing importance of AI and other new…
Finding new ways to avoid intraoperative anemia could go a long way toward improving outcomes for female CABG patients. The full analysis, based on more than…
“CT-FFR makes the CT ‘better’, but we found that the benefits were highest when used selectively,” one radiologist explained.
“CT-FFR makes the CT ‘better’, but we found that the benefits were highest when used selectively,” one radiologist explained.
ACC.24, the American College of Cardiology’s annual meeting in Atlanta, featured the latest in cardiovascular research and technologies. Representatives from Cardiovascular Business were there in…
The doctor, 76, admitted to billing multiple insurance providers for office visits that never happened at all.
